Navigation Links
Canada: On Popular Demand, Tamiflu finds a Berth in the Directory of Patent Drugs

Toronto – The directory of patented drugs will play host to a new entrant - oseltamivir or popularly known as Tamiflu, according to the recent communique // by the Director of patent policy in Canada, Douglas Clark. This is indeed a shot in the arm for the multitude of generic drug manufacturers, who can now avail the license to manufacture, and export the drug to developing nations.

Biolyse Pharma Corp., a leading pharmaceutical company, holds promise with its drug production capacity hovering between 500,000 and one million oseltamivir pills on a single day. The company is working towards its immediate goal of ensuring that the drugs hit the shelf in the next 6 months.

Swiss drug maker Hoffman-La Roche, a patent holder for Tamiflu, is working overtime to hoard the drug, needed to defend a potential influenza pandemic. Apparently, the company has not taken the Biolyse's bid too well.
SAV
'"/>




Page: 1

Related medicine news :

1. Canada: Time up for Health Care revamp
2. Incidence Of Smoking Less, Obesity More, in Canada: StatsCan
3. Canada: A long way to go on HIV/AIDS initiatives
4. Uterine Fibroid Embolization Gaining Popularity
5. Study Warns About The Use Of Popular Asthma Drug To Stop Childrens Coughs
6. Popularity Of Homeopathy On The Increase
7. Popularity Among Peers Increases Susceptibility To Smoking Habit Among School Children
8. Valentine Day Becoming Popular In India
9. Bio-functional Garments Gaining Popularity
10. Warfarin the Not So Popular Drug for Stroke
11. Tooth Enamel Eaten Away By Popular Drinks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... ... “They Sang At Her Funeral”: a tale of murder that will bring ... their closets. “They Sang At Her Funeral” is the creation of published author, Annalise ... five children and twelve grandchildren. Before becoming a writer, Annalise had the opportunity to ...
(Date:9/19/2017)... ... 2017 , ... Only a few physicians were selected to receive the prestigious ... Clevens, MD, FACS . The founder and medical director of Clevens Face and ... at Yale, Harvard and the University of Michigan. He has served patients throughout Central ...
(Date:9/19/2017)... ... , ... Trusted debt-reduction firm CreditAssociates, LLC has announced two important milestones. To ... $835 million in resolved debt for its clients. , Credit card debt, unpaid hospital ... of debt settled by the company. With more than a decade of combined service ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... Texas as a part of its national Swirl: A Wine Tasting Event series ...
(Date:9/19/2017)... ... September 19, 2017 , ... MelaKids, a Laredo-based company, has ... filter. When we’re born, Nature gives us a full supply of melanin – ... we continuously lose this natural glare-reducing pigment; however, around the age of thirty, we ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017  Medical ... knowledge and skills while treating their patients. ... hands-on experience without involving patients. Simulation provides ... Clinicians can carry out procedures, refine techniques ... risk. Integration of new technology, such as ...
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... Sept. 5, 2017  Getinge, a leading global ... vibrant charitable donation program -- "Color for the ... heart defect research by The Children,s Heart Foundation. ... general public are encouraged to download a coloring ... completed artwork to the gallery on the website. ...
Breaking Medicine Technology: